| scholarly article | Q13442814 |
| P50 | author | Shuo Qie | Q80664971 |
| P2093 | author name string | Meng Dong | |
| Fengmei Zhang | |||
| Lin Miao | |||
| Jingzhi Han | |||
| Ruohui Yu | |||
| Shengshui Li | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches | Q26752576 | ||
| Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism | Q27678762 | ||
| An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model | Q27853369 | ||
| Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects | Q28076454 | ||
| Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma | Q28239503 | ||
| ONCOMINE: a cancer microarray database and integrated data-mining platform | Q28255103 | ||
| The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
| Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
| SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis | Q30670039 | ||
| Systemic therapy for advanced hepatocellular carcinoma: an update | Q33593213 | ||
| From Krebs to clinic: glutamine metabolism to cancer therapy. | Q33834498 | ||
| The NF-κB member p65 controls glutamine metabolism through miR-23a. | Q34277479 | ||
| Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. | Q34645070 | ||
| Targeting mitochondrial glutaminase activity inhibits oncogenic transformation | Q34807996 | ||
| Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma | Q35781367 | ||
| Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. | Q35836097 | ||
| Carbon source metabolism and its regulation in cancer cells | Q35861635 | ||
| MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma | Q35879717 | ||
| ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation | Q35899955 | ||
| The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells | Q36189879 | ||
| NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells | Q36255581 | ||
| Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming | Q36338778 | ||
| The Emerging Hallmarks of Cancer Metabolism | Q36468964 | ||
| Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis. | Q36568490 | ||
| Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma | Q36750665 | ||
| LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer. | Q37015893 | ||
| Changing epidemiology of hepatocellular carcinoma in Asia | Q38664224 | ||
| PPARα Downregulates Hepatic Glutaminase Expression in Mice Fed Diets with Different Protein:Carbohydrate Ratios | Q38755222 | ||
| Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma | Q46089793 | ||
| Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors | Q80664973 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3721-3729 | |
| P577 | publication date | 2018-06-28 | |
| P1433 | published in | OncoTargets and Therapy | Q7092081 |
| P1476 | title | Nuclear factor-κB p65 regulates glutaminase 1 expression in human hepatocellular carcinoma | |
| P478 | volume | 11 |
Search more.